Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases

Acta Neuropathologica

Volumn 122, Issue 6, 2011, Pages 737-745

  Venneti, Sriram ^a   Robinson, John L ^b   Roy, Subhojit ^c   White, Matthew T ^b   Baccon, Jennifer ^d   Xie, Sharon X ^b   Trojanowski, John Q ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Biopsy; Diagnosis; Neurodegeneration; Synucleinopathies; Tauopathies

Indexed keywords

ALPHA SYNUCLEIN; DIRECT YELLOW 7; EOSIN; HEMATOXYLIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; THIOFLAVINE; UBIQUITIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN BIOPSY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARIETAL CORTEX; PICK PRESENILE DEMENTIA; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SIMULATION; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; AUTOPSY; BASAL GANGLIA; BIOPSY; BRAIN; CASE-CONTROL STUDIES; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

EID: 82355191790     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-011-0880-5     Document Type: Article

References (38)

1. (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18:S1-S2
2. MS Albert ST Dekosky D Dickson, et al. 2011 The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 270 279 21514249 10.1016/j.jalz.2011.03.008
3. H Braak K Del Tredici U Rub, et al. 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 12498954 10.1016/S0197-4580(02)00065-9 (Pubitemid 36007810)
4. JD Burns RO Cadigan JA Russell 2009 Evaluation of brain biopsy in the diagnosis of severe neurologic disease of unknown etiology Clin Neurol Neurosurg 111 235 239 19022558 10.1016/j.clineuro.2008.10.003
5. NJ Cairns EH Bigio IR Mackenzie, et al. 2007 Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 5 22 17579875 10.1007/s00401-007-0237-2 (Pubitemid 47029055)
6. J Cohen 1960 A coefficient of agreement for nominal scales Educ Psychol Meas 20 37 46 10.1177/001316446002000104
7. C Colosimo AJ Hughes L Kilford AJ Lees 2003 Lewy body cortical involvement may not always predict dementia in Parkinson's disease J Neurol Neurosurg Psychiatry 74 852 856 12810766 10.1136/jnnp.74.7.852 1:STN:280:DC%2BD3s3otlOjsQ%3D%3D (Pubitemid 36782982)
8. MS Forman J Farmer JK Johnson, et al. 2006 Frontotemporal dementia: clinicopathological correlations Ann Neurol 59 952 962 16718704 10.1002/ana.20873 (Pubitemid 43830927)
9. WR Gibb AJ Lees 1989 The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease Neuropathol Appl Neurobiol 15 27 44 2542825 10.1111/j.1365-2990.1989.tb01147.x 1:STN:280:DyaL1M3mt1Cquw%3D%3D (Pubitemid 19074096)
10. R Hamilton S Patel EB Lee, et al. 2011 Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology Ann Neurol 68 535 540 10.1002/ana.22015
11. A Hirano 1996 Neuropathology of ALS: an overview Neurology 47 S63 S66 8858053 1:STN:280:DyaK2s%2FhtFShsg%3D%3D
12. WT Hu A Chen-Plotkin SE Arnold, et al. 2010 Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease Acta Neuropathol 120 385 399 20652578 10.1007/s00401-010-0723-9
13. CR Jack Jr MS Albert DS Knopman, et al. 2011 Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 257 262 21514247 10.1016/j.jalz.2011.03.004
14. SP Javedan RJ Tamargo 1997 Diagnostic yield of brain biopsy in neurodegenerative disorders Neurosurgery 41 823 828 9316043 10.1097/00006123- 199710000-00011 1:STN:280:DyaK2svmtFOlug%3D%3D (discussion 828-830) (Pubitemid 27422109)
15. SA Josephson AM Papanastassiou MS Berger, et al. 2007 The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia J Neurosurg 106 72 75 17236490 10.3171/jns.2007.106.1.72 (Pubitemid 46120134)
16. BK Kleinschmidt-DeMasters RA Prayson 2006 An algorithmic approach to the brain biopsy-part I Arch Pathol Lab Med 130 1630 1638 17076524 1:STN:280:DC%2BD28nkt1ylug%3D%3D
17. JR Landis CG Koch 1977 The measurement of observer agreement for categorical data Biometrics 33 159 174 843571 10.2307/2529310 1:STN:280:DyaE2s7jsFWqtA%3D%3D (Pubitemid 8054849)
18. V Leinonen AM Koivisto S Savolainen, et al. 2010 Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease Ann Neurol 68 446 453 20976765 10.1002/ana.22100 1:CAS:528:DC%2BC3cXhsVOrur7N
19. I Litvan JJ Hauw JJ Bartko, et al. 1996 Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders J Neuropathol Exp Neurol 55 97 105 8558176 10.1097/00005072-199601000-00010 1:STN:280:DyaK287js1Wlsw%3D%3D (Pubitemid 26013790)
20. IG McKeith DW Dickson J Lowe, et al. 2005 Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 1863 1872 16237129 10.1212/01.wnl.0000187889.17253.b1 1:STN:280: DC%2BD2Mnpt1GqsQ%3D%3D (Pubitemid 43970103)
21. GM McKhann MS Albert M Grossman, et al. 2001 Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch Neurol 58 1803 1809 11708987 10.1001/archneur.58.11.1803 1:STN:280:DC%2BD3MnosFymsQ%3D%3D (Pubitemid 33044246)
22. GM McKhann DS Knopman H Chertkow, et al. 2011 The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 263 269 21514250 10.1016/j.jalz.2011.03. 005
23. Montine T, Hyman B, Beach T et al (2011) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer Dement (in press)
24. ME Murray NR Graff-Radford OA Ross, et al. 2011 Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study Lancet Neurol 10 785 796 21802369 10.1016/S1474-4422(11) 70156-9
25. H Nakashima-Yasuda K Uryu J Robinson, et al. 2007 Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases Acta Neuropathol 114 221 229 17653732 10.1007/s00401-007-0261-2 1:CAS:528:DC%2BD2sXosFKrsLs%3D (Pubitemid 47226148)
26. M Neumann DM Sampathu LK Kwong, et al. 2006 Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 130 133 17023659 10.1126/science.1134108 1:CAS:528:DC%2BD28XhtVCiurrL (Pubitemid 44547757)
27. E Noe K Marder KL Bell, et al. 2004 Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia Mov Disord 19 60 67 14743362 10.1002/mds.10633 (Pubitemid 38559622)
28. Pepe MS (2003) The statistical evaluation of medical tests for classification and prediction. Oxford University Press, Oxford
29. RA Prayson BK Kleinschmidt-DeMasters 2006 An algorithmic approach to the brain biopsy-part II Arch Pathol Lab Med 130 1639 1648 17076525
30. H Pulhorn DG Quigley JJ Bosma, et al. 2008 Impact of brain biopsy on the management of patients with nonneoplastic undiagnosed neurological disorders Neurosurgery 62 833 837 18496189 10.1227/01.neu.0000318168.97966.17 (discussion 837-838)
31. J Quinn D Spiro M Schulder 2011 Stereotactic brain biopsy with a low-field intraoperative magnetic resonance imager Neurosurgery 68 217 224 21206306 10.1227/NEU.0b013e31820826c2 (discussion 224)
32. Rice CM, Gilkes CE, Teare E et al (2011) Brain biopsy in cryptogenic neurological disease. Br J Neurosurg
33. JM Schott L Reiniger M Thom, et al. 2010 Brain biopsy in dementia: clinical indications and diagnostic approach Acta Neuropathol 120 327 341 20640903 10.1007/s00401-010-0721-y
34. RA Sperling PS Aisen LA Beckett, et al. 2011 Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 280 292 21514248 10.1016/j.jalz.2011.03.003
35. K Uryu H Nakashima-Yasuda MS Forman, et al. 2008 Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies J Neuropathol Exp Neurol 67 555 564 18520774 10.1097/NEN.0b013e31817713b5 1:CAS:528:DC%2BD1cXotVant7g%3D (Pubitemid 351787082)
36. JD Warren JM Schott NC Fox, et al. 2005 Brain biopsy in dementia Brain 128 2016 2025 15901648 10.1093/brain/awh543 1:STN:280:DC%2BD2MvmtFGrtA%3D%3D (Pubitemid 41253269)
37. SH Wong MD Jenkinson B Faragher, et al. 2010 Brain biopsy in the management of neurology patients Eur Neurol 64 42 45 20606447 10.1159/000315032 1:STN:280:DC%2BC3cjisFCmsw%3D%3D
38. Y Wu W Le J Jankovic 2011 Preclinical biomarkers of Parkinson disease Arch Neurol 68 22 30 21220674 10.1001/archneurol.2010.321